The optimal treatment time for slowing the progression of rheumatoid arthritis is earlier in the course of disease, researchers said in the Annals of Rheumatic Diseases.
For patients with rheumatoid arthritis (RA), moderate changes in lipids are observed after treatment with tocilizumab or tofacitinib, according to a review published in the January issue of Arthritis & Rheumatology.
Rheumatoid arthritis patients may get relief from a selective cannabinoid receptor agonist, according to findings published in BMC Musculoskeletal Disorders.
Study results show patients with psoriatic arthritis, rheumatoid arthritis, and psoriasis are at higher risk for myocardial infarction, stroke, and other adverse cardiovascular events.
Patients misunderstood onset causes, progression, and treatments for rheumatoid arthritis and spondyloarthritis, according to research published in PLOS One.
There is no difference in bone mineral density loss among pre- and postmenopausal women with rheumatoid arthritis, according to research from the Babol University of Medical Sciences in Iran.